A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)
Phase of Trial: Phase I
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Abatacept (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions
- 05 Jul 2017 Last checked against the ClinicalTrials.gov record.
- 30 Jun 2017 Planned End Date changed from 1 Jan 2017 to 1 Dec 2024.
- 15 Feb 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2019.